Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of Ertugliflozin on Kidney Outcomes in Patients With Heart Failure at Baseline in the Evaluation of Ertugliflozin Efficacy and Safety Cardiovascular Outcomes (VERTIS CV) Trial.
Cherney DZI, Cosentino F, McGuire DK, Kolkailah AA, Dagogo-Jack S, Pratley RE, Frederich R, Maldonado M, Liu CC, Cannon CP; VERTIS CV Investigators. Cherney DZI, et al. Among authors: kolkailah aa. Kidney Int Rep. 2023 Jan 20;8(4):746-753. doi: 10.1016/j.ekir.2023.01.011. eCollection 2023 Apr. Kidney Int Rep. 2023. PMID: 37069970 Free PMC article.
Heart failure outcomes captured by adverse event reporting in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial.
Pandey A, Kolkailah AA, McGuire DK, Frederich RC, Cater NB, Cosentino F, Pratley RE, Dagogo-Jack S, Cherney DZI, Wynant W, Gantz I, Mancuso JP, Masiukiewicz U, Cannon CP. Pandey A, et al. Among authors: kolkailah aa. Eur J Heart Fail. 2025 Jan 10. doi: 10.1002/ejhf.3511. Online ahead of print. Eur J Heart Fail. 2025. PMID: 39792342
Hypoglycemia and Cardiovascular Outcomes in the CARMELINA and CAROLINA Trials of Linagliptin: A Secondary Analysis of Randomized Clinical Trials.
Marx N, Kolkailah AA, Rosenstock J, Johansen OE, Cooper ME, Alexander JH, Toto RD, Wanner C, Espeland MA, Mattheus M, Schnaidt S, Perkovic V, Gollop ND, McGuire DK. Marx N, et al. Among authors: kolkailah aa. JAMA Cardiol. 2024 Feb 1;9(2):134-143. doi: 10.1001/jamacardio.2023.4602. JAMA Cardiol. 2024. PMID: 38170502 Free PMC article.
Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial.
Pandey A, Kolkailah AA, Cosentino F, Cannon CP, Frederich RC, Cherney DZI, Dagogo-Jack S, Pratley RE, Cater NB, Gantz I, Mancuso JP, McGuire DK. Pandey A, et al. Among authors: kolkailah aa. Eur Heart J. 2023 Dec 21;44(48):5163-5166. doi: 10.1093/eurheartj/ehad639. Eur Heart J. 2023. PMID: 37864578 Free PMC article. No abstract available.
43 results